Literature DB >> 20882900

A case of ovarian endometrioid adenocarcinoma with yolk sac tumor in a 35-year-old woman.

D G Hong1, G O Chong, W J Seong, Y S Lee, Y L Cho, J Y Park, J M Chae, I S Park.   

Abstract

Ovarian yolk sac tumor (YST) is a malignant ovarian neoplasm differentiated from primordial germ cells that occur in young age, while endometrioid carcinoma (ECA) is a müllerian epithelial tumor that usually occurs in older patients. The coexistence of an ovarian ECA and YST component is very rare. Only 12 cases have been reported until now according to a Medline search of the English literatures. We present a case of a simultaneous ECA and a YST component in a 35-year-old woman. Exploratory laparotomy was performed. The parts of both ovaries that showed an endometrioid-like glandular pattern were positive for cytokeratin 7 and negative for AFP, but the YST component was negative for cytokeratin 7 and positive for AFP. After completion of four courses of BEP chemotherapy, two courses of taxane and carboplatin chemotherapy were added. The patient failed to respond and succumbed to the disease after 12 months of follow-up.

Entities:  

Mesh:

Year:  2010        PMID: 20882900

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  3 in total

1.  Ovarian malignant mixed germ cell tumor with clear cell carcinoma in a postmenopausal woman.

Authors:  Xiu-Jie Yu; Lin Zhang; Zai-Ping Liu; Yi-Quan Shi; Yi-Xin Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

2.  A case of ovarian yolk sac tumor associated with endometrioid adenocarcinoma.

Authors:  Chiho Koi; Tomoko Kurita; Seiji Kagami; Atsuji Matsuyaya; Toru Hachisuga
Journal:  Gynecol Oncol Case Rep       Date:  2014-04-29

3.  A case of ovarian endometrioid adenocarcinoma with yolk sac differentiation and Lynch syndrome.

Authors:  Janhvi Sookram; Brooke Levin; Julieta Barroeta; Kathy Kenley; Pallav Mehta; Lauren S Krill
Journal:  Gynecol Oncol Rep       Date:  2019-01-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.